OVIVA THERAPEUTICS
Live / Registered — Registered (as of 29 Oct 2024)
What this means for you
Registered since 29 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97603698
- Registration number
- 7547212
- Mark type
- Stylized text
- Filed
- 23 Sept 2022
- Published for opposition
- 13 Aug 2024
- Registered
- 29 Oct 2024
- Attorney of record
- Matthew D. Delaney
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of ovarian function; Research and development in the field of female physiology; Scientific research for medical purposes in the field of ovarian function; Scientific research for medical purposes in the field of female physiology
Owner
- Cambrian BioPharma, Inc., New York, NY, US
- Cambrian BioPharma, Inc., New York, NY, US
- Cambrian BioPharma, Inc., New York, NY, US
Prosecution history
- 29 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION
- 24 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jul 2024 — ASSIGNED TO LIE
- 10 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Nov 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Oct 2023 — NON-FINAL ACTION E-MAILED